These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The Gorman JA; Hundhausen C; Kinsman M; Arkatkar T; Allenspach EJ; Clough C; West SE; Thomas K; Eken A; Khim S; Hale M; Oukka M; Jackson SW; Cerosaletti K; Buckner JH; Rawlings DJ Front Immunol; 2019; 10():44. PubMed ID: 30740104 [TBL] [Abstract][Full Text] [Related]
6. Two rare disease-associated Tyk2 variants are catalytically impaired but signaling competent. Li Z; Gakovic M; Ragimbeau J; Eloranta ML; Rönnblom L; Michel F; Pellegrini S J Immunol; 2013 Mar; 190(5):2335-44. PubMed ID: 23359498 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of TYK2 and JAK1 ameliorates imiquimod-induced psoriasis-like dermatitis by inhibiting IL-22 and the IL-23/IL-17 axis. Works MG; Yin F; Yin CC; Yiu Y; Shew K; Tran TT; Dunlap N; Lam J; Mitchell T; Reader J; Stein PL; D'Andrea A J Immunol; 2014 Oct; 193(7):3278-87. PubMed ID: 25156366 [TBL] [Abstract][Full Text] [Related]
8. Tyrosine kinase 2 is not limiting human antiviral type III interferon responses. Fuchs S; Kaiser-Labusch P; Bank J; Ammann S; Kolb-Kokocinski A; Edelbusch C; Omran H; Ehl S Eur J Immunol; 2016 Nov; 46(11):2639-2649. PubMed ID: 27615517 [TBL] [Abstract][Full Text] [Related]
9. Identification of rare coding variants in Motegi T; Kochi Y; Matsuda K; Kubo M; Yamamoto K; Momozawa Y Ann Rheum Dis; 2019 Aug; 78(8):1062-1069. PubMed ID: 31118190 [TBL] [Abstract][Full Text] [Related]
10. A restricted role for TYK2 catalytic activity in human cytokine responses revealed by novel TYK2-selective inhibitors. Sohn SJ; Barrett K; Van Abbema A; Chang C; Kohli PB; Kanda H; Smith J; Lai Y; Zhou A; Zhang B; Yang W; Williams K; Macleod C; Hurley CA; Kulagowski JJ; Lewin-Koh N; Dengler HS; Johnson AR; Ghilardi N; Zak M; Liang J; Blair WS; Magnuson S; Wu LC J Immunol; 2013 Sep; 191(5):2205-16. PubMed ID: 23894201 [TBL] [Abstract][Full Text] [Related]
11. Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome. Kreins AY; Ciancanelli MJ; Okada S; Kong XF; Ramírez-Alejo N; Kilic SS; El Baghdadi J; Nonoyama S; Mahdaviani SA; Ailal F; Bousfiha A; Mansouri D; Nievas E; Ma CS; Rao G; Bernasconi A; Sun Kuehn H; Niemela J; Stoddard J; Deveau P; Cobat A; El Azbaoui S; Sabri A; Lim CK; Sundin M; Avery DT; Halwani R; Grant AV; Boisson B; Bogunovic D; Itan Y; Moncada-Velez M; Martinez-Barricarte R; Migaud M; Deswarte C; Alsina L; Kotlarz D; Klein C; Muller-Fleckenstein I; Fleckenstein B; Cormier-Daire V; Rose-John S; Picard C; Hammarstrom L; Puel A; Al-Muhsen S; Abel L; Chaussabel D; Rosenzweig SD; Minegishi Y; Tangye SG; Bustamante J; Casanova JL; Boisson-Dupuis S J Exp Med; 2015 Sep; 212(10):1641-62. PubMed ID: 26304966 [TBL] [Abstract][Full Text] [Related]
13. Expression of Tyk2 in dendritic cells is required for IL-12, IL-23, and IFN-gamma production and the induction of Th1 cell differentiation. Tokumasa N; Suto A; Kagami S; Furuta S; Hirose K; Watanabe N; Saito Y; Shimoda K; Iwamoto I; Nakajima H Blood; 2007 Jul; 110(2):553-60. PubMed ID: 17395783 [TBL] [Abstract][Full Text] [Related]
14. Tyk2-dependent bystander activation of conventional and nonconventional Th1 cell subsets contributes to innate host defense against Listeria monocytogenes infection. Hashiguchi T; Oyamada A; Sakuraba K; Shimoda K; Nakayama KI; Iwamoto Y; Yoshikai Y; Yamada H J Immunol; 2014 May; 192(10):4739-47. PubMed ID: 24729620 [TBL] [Abstract][Full Text] [Related]
15. Differential requirements for JAK2 and TYK2 in T cell proliferation and IFN-gamma production induced by IL-12 alone or together with IL-18. Sugimoto N; Nakahira M; Ahn HJ; Micallef M; Hamaoka T; Kurimoto M; Fujiwara H Eur J Immunol; 2003 Jan; 33(1):243-51. PubMed ID: 12594853 [TBL] [Abstract][Full Text] [Related]
16. Influence of TYK2 in systemic sclerosis susceptibility: a new locus in the IL-12 pathway. López-Isac E; Campillo-Davo D; Bossini-Castillo L; Guerra SG; Assassi S; Simeón CP; Carreira P; Ortego-Centeno N; García de la Peña P; ; Beretta L; Santaniello A; Bellocchi C; Lunardi C; Moroncini G; Gabrielli A; Riemekasten G; Witte T; Hunzelmann N; Kreuter A; Distler JH; Voskuyl AE; de Vries-Bouwstra J; Herrick A; Worthington J; Denton CP; Fonseca C; Radstake TR; Mayes MD; Martín J Ann Rheum Dis; 2016 Aug; 75(8):1521-6. PubMed ID: 26338038 [TBL] [Abstract][Full Text] [Related]
17. Two common disease-associated TYK2 variants impact exon splicing and TYK2 dosage. Li Z; Rotival M; Patin E; Michel F; Pellegrini S PLoS One; 2020; 15(1):e0225289. PubMed ID: 31961910 [TBL] [Abstract][Full Text] [Related]
18. Human ancient DNA analyses reveal the high burden of tuberculosis in Europeans over the last 2,000 years. Kerner G; Laval G; Patin E; Boisson-Dupuis S; Abel L; Casanova JL; Quintana-Murci L Am J Hum Genet; 2021 Mar; 108(3):517-524. PubMed ID: 33667394 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive assessment of the association between genes on JAK-STAT pathway (IFIH1, TYK2, IL-10) and systemic lupus erythematosus: a meta-analysis. Yin Q; Wu LC; Zheng L; Han MY; Hu LY; Zhao PP; Bai WY; Zhu XW; Xia JW; Wang XB; Zhang XW; Zheng HF Arch Dermatol Res; 2018 Nov; 310(9):711-728. PubMed ID: 30171347 [TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Suppresses Type I Interferon Signaling To Promote EBV Reactivation. Liu X; Sadaoka T; Krogmann T; Cohen JI J Virol; 2020 May; 94(11):. PubMed ID: 32213613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]